SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response.

Yuki Takamatsu; Kazumi Omata; Yosuke Shimizu; Noriko Kinoshita-Iwamoto; Mari Terada; Tetsuya Suzuki; Shinichiro Morioka; Yukari Uemura; Norio Ohmagari; Kenji Maeda; Hiroaki Mitsuya.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-495422

Documentos relacionados

  1. SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response.
  2. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
  3. Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
  4. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
  5. Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy.
  6. Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study.
  7. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
  8. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.
  9. Production and use of convalescent plasma in COVID-19 treatment, taking into account the experience in the Central Millitary Hospital Prague.
  10. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.